The resumed production of GE Healthcare’s Omnipaque products is a welcome development for radiologists scrambling to come up with alternative dosing and imaging options in the past month during the temporary shortage of iodinated contrast media.
With the easing of COVID-19 restrictions in Shanghai, GE Healthcare recently announced that the production of iodinated contrast media (ICM) with the Omnipaque products (iohexol) at its Shanghai plant will “be close to 100 percent” starting on Monday, June 6.
“This will enable us to restabilize our global supply of iodinated contrast media,” emphasized GE Healthcare in the update statement.
In a recent interview (see video clip below), Joseph Cavallo, M.D., said the temporary shortage of iodinated contrast media also represented an opportunity to reexamine imaging protocols and identify where non-contrast imaging or alternative imaging could be viable options moving forward without affecting image quality.
“Especially with some of the newer scanners, many imaging protocols out there probably overdose, to a certain degree, the iodinated contrast media,” suggested Dr. Cavallo, an assistant professor of radiology and biomedical imaging at the Yale University School of Medicine.
(Editor's note: For related content, see "Iodinated Contrast Media: Practical Solutions and Applications in Radiology.")
Dr. Cavallo said modification of imaging protocols could also lead to reduced expenses as well as a reduction in the amount of radiation dosing that patients are exposed to.
In a separate interview, Sean Bryant, M.D., the owner and president of Diversified Radiology, concurred that during the daily hustle and bustle of practice, there is a tendency for “protocol creep” to occur. He acknowledged that the ICM shortage compelled radiologists to modify their protocols by incorporating updates from recent literature and emerging recommendations from the American College of Radiology.
However, Dr. Bryant, a neuroradiologist, also emphasized preserving contrast use when appropriate and not trying to “shave off a little bit of volume just to save a few dollars.
“I want us to be careful on a slippery slope of just trying to reduce the doses without a really compelling or emergent reason to change policy,” noted Dr. Bryant, a clinical assistant professor in the department of neuroradiology at the University of Colorado Health Sciences Center and the University of California San Francisco.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.